Discounting costs and health benefits in cost-effectiveness analysis has been the subject of recent debate -some authors suggesting a common rate for both and others suggesting a lower rate for health. We show how these views turn on key judgments of fact and value: on whether the social objective i
✦ LIBER ✦
The economic evaluation of prevention – Let’s talk about values and the case of discounting
✍ Scribed by David L. B. Schwappach
- Publisher
- SP Birkhäuser Verlag Basel
- Year
- 2007
- Tongue
- English
- Weight
- 103 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1661-8556
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Discounting and decision making in the e
✍
Karl Claxton; Mike Paulden; Hugh Gravelle; Werner Brouwer; Anthony J. Culyer
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 150 KB
👁 2 views
Cost analysis of filgrastim for the prev
✍
Bennett, Charles L.; Stinson, Tammy J.; Lane, David; Amylon, Michael; Land, Vita
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 112 KB
👁 2 views
Background. Growth factor use has been shown to ameliorate chemotherapy-induced neutropenia, leading to shorter hospital stays and lower use of parenteral antibiotics, two costly areas of cancer treatment. Prior reports on pediatric patients have shown evidence of cost savings in some studies, but n
The Production of oil of American Wormse